Literature DB >> 29912303

Early Juvenile Human T-cell Lymphotropic Virus Type-1-Associated Myelopathy/Tropical Spastic Paraparesis: Study of 25 Patients.

Cinthya Maria Neves Varandas1, José Lucas Sena da Silva2, Janeusa Rita L Primo1,3, Maria de Fátima S P de Oliveira3, Otávio Moreno-Carvalho3, Lourdes Farre4,5, Achiléa L Bittencourt2.   

Abstract

Background: Human T-cell lymphotropic virus type-1 (HTLV-1) may cause severe diseases such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH). The clinical characteristics and progression of 25 early onset HAM/TSP associated or not to IDH were described.
Methods: Following-up 37 IDH patients with neurological examinations, 54% developed HAM/TSP. To these cases were added 5 cases of juvenile HAM/TSP. The patients were HTLV-1+ and were submitted to dermatological and neurological examinations. Diagnosis of HAM/TSP was performed according to Osame et al (1990) and Castro-Costa et al (2006) criteria.
Results: Twenty-one patients were classified as definite HAM/TSP by both criteria, 3 as probable HAM/TSP by Osame et al, and another as probable HAM/TSP according to Castro-Costa et al Median age at onset of neurological manifestations was 9 years for the IDH/HAM/TSP group and 16 years for the HAM/TSP group (P = .045). In 12 patients, the onset of neurological manifestations occurred when they were less than 10 years of age. In the group IDH/HAM/TSP, the neurological symptoms always begun during the period of activity of IDH. The progression of HAM/TSP evaluated in 17 cases was heterogeneous, and 3 had rapid progressive course. Conclusions: The juvenile HAM/TSP may occur very early and also presents marked female predominance. Progression of IDH to HAM/TSP before 19 years of age is frequent (54%). Rapid progressive form may also occur in early HAM/TSP. As juvenile IDH and HAM/TSP are due to vertical transmission through breastfeeding, it is very important to avoid this pathway of infection.

Entities:  

Mesh:

Year:  2018        PMID: 29912303     DOI: 10.1093/cid/ciy289

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

Review 1.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

2.  Cabotegravir, the Long-Acting Integrase Strand Transfer Inhibitor, Potently Inhibits Human T-Cell Lymphotropic Virus Type 1 Transmission in vitro.

Authors:  Bethany S Schneiderman; Michal S Barski; Goedele N Maertens
Journal:  Front Med (Lausanne)       Date:  2022-04-25

3.  Estimation of HTLV-1 vertical transmission cases in Brazil per annum.

Authors:  Carolina Rosadas; Bassit Malik; Graham P Taylor; Marzia Puccioni-Sohler
Journal:  PLoS Negl Trop Dis       Date:  2018-11-12

4.  HTLV-1 proviral load in infective dermatitis associated with HTLV-1 does not increase after the development of HTLV-1-associated myelopathy/tropical spastic paraparesis and does not decrease after IDH remission.

Authors:  Everton S Batista; Pedro D Oliveira; Janeusa Primo; Cinthya Maria Neves Varandas; Ana Paula Nunes; Achiléa L Bittencourt; Lourdes Farre
Journal:  PLoS Negl Trop Dis       Date:  2019-12-18

Review 5.  Extracellular Vesicles in HTLV-1 Communication: The Story of an Invisible Messenger.

Authors:  Sarah Al Sharif; Daniel O Pinto; Gifty A Mensah; Fatemeh Dehbandi; Pooja Khatkar; Yuriy Kim; Heather Branscome; Fatah Kashanchi
Journal:  Viruses       Date:  2020-12-10       Impact factor: 5.048

Review 6.  HTLV-1 and Co-infections.

Authors:  Carolina Rosadas; Graham P Taylor
Journal:  Front Med (Lausanne)       Date:  2022-02-03

Review 7.  Influence of Immunogenetic Biomarkers in the Clinical Outcome of HTLV-1 Infected Persons.

Authors:  Antonio Carlos Rosário Vallinoto; Izaura Cayres-Vallinoto; Maria Alice Freitas Queiroz; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak
Journal:  Viruses       Date:  2019-10-23       Impact factor: 5.048

8.  Clinicopathological aspects and proviral load of adulthood infective dermatitis associated with HTLV-1: Comparison between juvenile and adulthood forms.

Authors:  Lucca Santos Souza; Thadeu Santos Silva; Maria de Fátima Paim de Oliveira; Lourdes Farre; Achiléa Lisboa Bittencourt
Journal:  PLoS Negl Trop Dis       Date:  2020-04-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.